Does the Amount of Malignant Pleural Effusion Affect the Survival in Patients with Non-Small Cell Lung Cancer?

被引：0
|
作者：
Nakamura, Shota [1 ]
Okasaka, Toshiki [1 ]
Kawaguchi, Koji [1 ]
Fukui, Takayuki [1 ]
Fukumoto, Koichi [1 ]
Yokoi, Kohei [1 ]
机构：
[1] Nagoya Univ, Thorac Surg, Nagoya, Aichi 4648601, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
non-small cell lung cancer; TNM classification; malignant pleural effusion; malignant pleuritis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.04-128
引用
收藏
页码：S727 / S727
页数：1
相关论文
共 50 条
  • [1] Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control
    Hsu, I-Lin
    Su, Wu-Chou
    Yan, Jing-Jou
    Chang, Jia-Ming
    Lai, Wu-Wei
    LUNG CANCER, 2009, 65 (03) : 371 - 376
  • [2] Predictive model for sarcopenia in patients with non-small cell lung cancer and malignant pleural effusion
    Gao, Hengxing
    Zou, Xuexue
    Fan, Meng
    Chen, Mingwei
    BMC CANCER, 2025, 25 (01)
  • [3] Predictors of survival in non-small cell lung cancer patients with pleural effusion undergoing thoracoscopy
    Xie, Li-Xu
    Wang, Xing-Guang
    You, Wen-Jie
    Ma, Xiao-Bin
    Wang, Yong-Gang
    Liu, Ting-Ting
    Jiang, Shu-Juan
    THORACIC CANCER, 2019, 10 (06) : 1412 - 1418
  • [4] MOLECULAR TESTING AND CYTOPATHOLOGIC FEATURES OF MALIGNANT PLEURAL EFFUSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Fujii, T.
    Fukawa, T.
    Kishi, K.
    Ohashi, K.
    ACTA CYTOLOGICA, 2010, 54 (03) : 414 - 414
  • [5] The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion
    Nagamine, Hiroaki
    Sawa, Kenji
    Kaneda, Hiroyasu
    Ogawa, Koichi
    Nakahama, Kenji
    Matsumoto, Yoshiya
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    ANNALS OF ONCOLOGY, 2022, 33 : S523 - S523
  • [6] The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer
    Fukuse, T
    Hirata, T
    Tanaka, F
    Wada, H
    LUNG CANCER, 2001, 34 (01) : 75 - 81
  • [7] The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
    Chen, Yao
    Mathy, Nicholas W.
    Lu, Hongda
    MOLECULAR MEDICINE REPORTS, 2018, 17 (06) : 8019 - 8030
  • [8] Prognostic value of pleural effusion in patients with non-small cell lung cancer
    Sugiura, S
    Ando, Y
    Minami, H
    Ando, M
    Sakai, S
    Shimokata, K
    CLINICAL CANCER RESEARCH, 1997, 3 (01) : 47 - 50
  • [9] EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING BEVACIZUMAB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Fujii, Mitsuhiro
    Iwakami, Shin-Ichiro
    Ihara, Hiroaki
    Hara, Munechika
    Iwakami, Naoko
    Ishiwata, Toshiji
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 87 - 87
  • [10] Development a predictive nomogram for spontaneous pleurodesis in patients with non-small cell lung cancer and malignant pleural effusion
    Tan, Sihan
    Zeng, Hao
    Huang, Qin
    Pu, Xin
    Li, Weimin
    Ali, Jason M.
    Nayak, Rahul
    Bhagat, Milind
    Li, Yalun
    Tian, Panwen
    JOURNAL OF THORACIC DISEASE, 2025, 17 (02)
12345